An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.
Eugene J. McNally
Advertisement
Eugene J. McNally, PhD, is vice-president, early engagement and regulatory strategy, Strategic Development Consulting, at PPD, part of Thermo Fisher Scientific.
Articles by Eugene J. McNally
An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.
Advertisement
Latest Updated Articles
Exploring an Intelligent Drug Development ParadigmPublished: August 2nd 2023 | Updated:
- An Intelligent Drug Development Paradigm
Published: August 3rd 2023 | Updated:
Advertisement
Advertisement
